What is the lead time for orders?

The average lead time is within 15 workdays.

What payment terms are accepted?

We accept LC, T/T, D/P, PayPal, and small-amount payments.

Low Energy 50lpm Medical Suction Swinging Piston Vacuum Pump

Name: Low Energy 50lpm Medical Suction Swinging Piston Vacuum Pump
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 2084096225

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$50.00-60.00

100 Pieces

Sample price:US$75.00/piece.Request sample

Product profile

Customization

Available

After-sales Service

on Line Support and Free Spare Parts

Air Flow

50 L/Min

Model NO.

SMV-50

Vacuum

-90kpa

Noise

≤52dB(a)

Brand Name

OEM

Voltage

220V 50Hz

Power Source

AC Power

Dimension

168X99X150 mm

Net Weight

3.5 Kg

Speed

1440rpm

Temperature

50° to 104°f(10° to 40°c)

Thermal Protector

145°c)

Package

Honeycomb Packaging

Certificate

ETL

HS Code

84141000

Production Capacity

500000 Piece/Year

Key features

High Vacuum Performance: Achieves a maximum vacuum level of -90kpa for efficient suction applications.

Low Noise Operation: Operates at a noise level of less than 52dB, ensuring a quiet working environment.

Compact and Lightweight: Dimensions of 168x99x150mm and a net weight of only 3.5kg for easy portability.

Versatile Applications: Suitable for medical suction, laboratory use, and vacuum packaging tasks.

Reliable Motor Design: Features a P.S.C motor with 4.5uF capacitance and Class B insulation.

Comprehensive Support: Provides online support and free spare parts for after-sales service.

Fast Lead Time: Average lead time within 15 workdays for both peak and off-season orders.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤8.43hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.